| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 4.440 | 39.673 | 37.069 | 9.291 | 9.836 | 14.236 | 13.997 |
| Total Income - EUR | - | - | 263 | 5.421 | 45.609 | 49.562 | 14.986 | 15.548 | 19.931 | 22.826 |
| Total Expenses - EUR | - | - | 91 | 17.641 | 43.743 | 45.531 | 24.503 | 19.875 | 14.610 | 23.585 |
| Gross Profit/Loss - EUR | - | - | 172 | -12.220 | 1.866 | 4.031 | -9.517 | -4.326 | 5.321 | -759 |
| Net Profit/Loss - EUR | - | - | 164 | -12.267 | 1.469 | 3.757 | -9.610 | -4.425 | 5.179 | -1.179 |
| Employees | - | - | 0 | 2 | 3 | 5 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Ash Medicalterapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 8 | 41.045 | 32.828 | 25.031 | 17.767 | 11.962 | 8.682 | 5.408 |
| Current Assets | - | - | 252 | 1.411 | 1.813 | 17.077 | 2.926 | 2.816 | 5.212 | 6.325 |
| Inventories | - | - | 0 | 479 | 46 | 0 | 0 | 130 | 85 | 0 |
| Receivables | - | - | 263 | 1.021 | 1.236 | 5.628 | 0 | 26 | 554 | 602 |
| Cash | - | - | -11 | -89 | 531 | 11.449 | 2.926 | 2.660 | 4.574 | 5.722 |
| Shareholders Funds | - | - | 208 | -12.063 | -10.360 | -6.407 | -13.706 | -18.174 | -12.940 | -14.047 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 52 | 14.502 | 13.506 | 23.626 | 13.750 | 18.032 | 17.652 | 22.390 |
| Income in Advance | - | - | 0 | 40.018 | 33.410 | 26.953 | 20.661 | 15.013 | 9.273 | 3.558 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ash Medicalterapy Srl